Announcements Trials
Browse Landscape

Phase

Phase 1 12Phase 1/2 8Phase NA 7Phase 2 3Phase 3 2Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1

Status

Completed 112Unknown 38Terminated 16Recruiting 16Withdrawn 9Active not recruiting 6Not yet recruiting 4Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lung Neoplasms 2Stomach Neoplasms 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Pneumonia 1Neoplasms 1Lung Diseases, Interstitial 1Infertility 1Chronic Pain 1Carcinoma, Non-Small-Cell Lung 1Cancer Pain 1Adenocarcinoma Of Esophagus 1

Interventions

abarelix 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Suspended × Neoplasms × Clear all
NCT00103623 2006-09-19

The Plenaxis® Experience Study

PRAECIS Pharmaceuticals Inc.

Phase 4 Suspended
2,000 enrolled
Genitourinary

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡